BenzingaOctober 22, 2026 at 8:37 AM NY5 Days Ago
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $775
Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $750 to $775.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
